期刊文献+

循证医学在糖尿病诊治中的应用 被引量:1

The effect of evidence-based medicine on the diagnosis and treatment of diabetes
下载PDF
导出
摘要 循证医学虽然在临床的应用时间不长,但它已经广泛用于指导临床的实践。糖尿病是近代发病率迅速增长的慢性代谢性疾病,随着循证医学实践的不断发展,在糖尿病的诊断及降压、降糖、调脂治疗方面均提出了全新的观点。这些观点对于全面提高临床实践中糖尿病的诊断及治疗水平,对于改善糖尿病人大小血管并发症的治疗效果及其预后、生存质量意义重大。 Evidence-based medicine(EBM) has been used greatly in clinical practice shortly after it was pointed out. Diabetes mellitus (DM) is a chronic metabolic disease, mortality of which is increasing dramatically in modern times. With the development of EBM, many new concepts were given to the diagnosis criteria of DM, the therapeutic goals of controlling blood pressure, blood glucose and blood lipid. All of these new concepts have played very important roles in the clinical practice of diabetic diagnosis and treatment; it is also very important in improving the curative effects of diabetic macrovascular and microvascular complications, diabetic patients' prognosis and living quality.
出处 《循证医学》 CSCD 2002年第2期88-90,93,共4页 The Journal of Evidence-Based Medicine
关键词 循证医学 糖尿病 诊断 治疗 EBM 高血糖 diabetes mellitus diagnosis treatment evidence-based medicine
  • 相关文献

参考文献16

  • 1Sackett D L, Straus S E. Evidence-based medicine: how to practice and teach evidence-based medicine [ M ]. Second Edition. Churchill Livingstone: Edinburgh, 2000
  • 2The DECODE study group on behalf of the European Diabetes Epidemiology Group. Consequences of the new diagnostic criteria for diabetes in older men and women [J]. Diabetes Care, 1999,22(10): 1667 - 1671
  • 3The DECODE study group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria[J]. Lancet, 1999, 354(9179): 617 - 621
  • 4The DECODE study group on behalf of the European Diabetes Epidemiology Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies [J] .Diabetologia, 1999, 42(6): 647 - 654
  • 5The Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of longterm complicationss in insulin-dependent diabetes mellitus [J]. N Engl Med, 1993, 329:977 - 986
  • 6Turner R. The UKPDS: a review [J]. Diabetes Care, 1998, 21(suppl 3): 35 -38
  • 7Feinglos M N, Bethel M A. Oral agent therapy in the treatment of type 2 diabetes [J]. Diabetes Care, 1999, 22(3): C61 -64
  • 8Buse J B. Overview of current therapeutic options in type 2diabetes: Rationale for combining oral agents with insulin therapy[J]. Diabetes Care,1999,22(3): C65 -70
  • 9Berger M, Jorgens V, Muhlhauser I. Rationale for the use of insulin therapy alone as the pharmacologieal treatment of type 2diabetes [J]. Diabetes Care, 1999, 22(3): C71 - 75
  • 10Hansson L, Zanchetti A, Carruthers S G, et al. Effect of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment(HOT) randomised trial [J]. Lancet, 1998, 351 (9118):1755 - 1762

同被引文献26

  • 1陈灏珠.内科学[M]:第4版[M].北京:人民卫生出版社,1997.854.
  • 2Sackett DL, Straus SE, Richanlson WS, et al. Evidence-based medicine:how to practice and teach evidence-based [M].Second Edition.Edinburgh : Churchill Livingstone, 2000.
  • 3Hami EH, Boutin P, Durand E, et al. Missense mutation in the pancreatic islet beta cell inwardly rectifying K^+ channel gene (kir6.2/Bir):a meta-analysis suggests a role in the polygenic basis of type 2 dibetes mellitus in Caucasions [J].Diabetologia, 1998,41 (2) : 1511.
  • 4Fujisawa T, Ikegami H, Kawaguchi Y, et al. Meta-analysi of the association of Trp64Arg polymorphysim of beta-3-adrenegic receptor gene with body mass index [J]. J Clin Endocrinol Metab, 1998,83(7) :2441.
  • 5Fujisawa T, Ikegami H, Kawaguchi Y, et al. Meta-analysi of association of insertion/deletion polymorphism of anglotension 1-converting enzyme gene with diabetic nephropathy and retionpathy [J]. Diabetologia, 1998,41(1):47.
  • 6Meigs JB, Panhwysen CIM, Myers RH, et al. A genome wide scan for locilinked to plasma levels of glucose and HbA1c in a community based sample of Caucasian Pedigrees [J]. Diabetes,2002,51 : 833 -840.
  • 7Mahtani MM, Widen E. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish Families [J]. Nat Genet, 1997,17(2) : 148.
  • 8West KM. Substantial differences in diagnostic critenria used by diabetes experts [J]. Daibetes, 1975,24:641-644.
  • 9Anon. World Health Organization Expert Committee Diabetes Mellitus:second report.WHO Technical Report Series 646[M]//Ceneva:WHO, 1980.
  • 10The DECODE study group on behalf of the European Diabetes Epidemiology Group.Consequences of the new diagnostic criteria for diabetes in older men and women [J]. Diabetes Care, 1999,22(10) : 1667-1671.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部